Palacio, Baby Boy .
HRN: 27-07-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/12/2025
05/18/2025
IV
37mg
Q24
Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes